The development of a rapid and efficient system to identify human immunodeficiency virus
type 1 (HIV-1)-infected individuals with broad and potent HIV-1-specific neutralizing antibody …

We conducted a prospective study among women in Mombasa, Kenya, to determine
whether Trichomonas vaginalis infection was associated with an increased risk of human …

We investigated the effect of human immunodeficiency virus type 1 (HIV-1) subtype on
disease progression among 145 Kenyan women followed from the time of HIV-1 acquisition. …

Background Emerging evidence suggests that after completion of treatment for tuberculosis (TB)
a significant proportion of patients experience sequelae. However, there is limited …

Background Clinical laboratory reference intervals have not been established in many
African countries, and non-local intervals are commonly used in clinical trials to screen and …

The determinants of a broad neutralizing antibody (NAb) response and its effect on human
immunodeficiency virus type 1 (HIV-1) disease progression are not well defined, partly …

Background Disruptions of vaginal microbiota might increase women's susceptibility to HIV
infection. Advances in molecular microbiology have enabled detailed examination of …

Objective: There is substantial epidemiological evidence that infection by Herpes simplex
virus type 2 (HSV2) enhances both HIV susceptibility and subsequent sexual transmission. …

Background. It has been suggested that vaginal colonization with lactobacilli may reduce the
risk of vulvovaginal candidiasis (VVC), but supporting data are limited. Our objective was to …

Background: Studies of the effect of hormonal contraceptive use on the risk of HIV-1 acquisition
have generated conflicting results. A recent study from Uganda and Zimbabwe found that …